Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and safety of 7 versus 14 days of antibiotic treatment for Pseudomonas aeruginosa bacteraemia: a multicentre, randomized clinical trial (SHORTEN-2) with a DOOR/RADAR analysis

Next Previous
Search
Trial Profile

Efficacy and safety of 7 versus 14 days of antibiotic treatment for Pseudomonas aeruginosa bacteraemia: a multicentre, randomized clinical trial (SHORTEN-2) with a DOOR/RADAR analysis

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Jun 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Amikacin (Primary) ; Avibactam/ceftazidime (Primary) ; Aztreonam (Primary) ; Cefepime (Primary) ; Ceftazidime (Primary) ; Ceftolozane/tazobactam (Primary) ; Ciprofloxacin (Primary) ; Ciprofloxacin (Primary) ; Colistin (Primary) ; Imipenem (Primary) ; Levofloxacin (Primary) ; Levofloxacin (Primary) ; Meropenem (Primary) ; Meropenem/vaborbactam (Primary) ; Piperacillin/tazobactam (Primary) ; Tobramycin (Primary)
  • Indications Bacteraemia; Pseudomonal infections
  • Focus Therapeutic Use
  • Acronyms SHORTEN2

    • Most Recent Events

    • 20 May 2022 Status changed from not yet recruiting to recruiting.
    • 31 Mar 2022 Planned initiation date changed from 1 Feb 2022 to 1 Apr 2022.
    • 20 Jan 2022 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top